Effects Of Etomidate and Propofol on Hemodynmics In Patients Planned For Off Pump CABG

Hemodynamic Effects Of Etomidate and Propofol Used As Induction Agents In Patients Planned For Off Pump CABG - Etomidate and Propofol comparison in CABG

Status

Active, not recruiting

Phases

Phase 4

Study type

Observational

Source

CTRI

Registry ID

CTRI/2016/04/006896

Enrollment

100

Registered

2016-04-29

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- ASA II and III

Interventions

Control Intervention1: Inj Propofol: Single dose of Inj Propofol 2mg per kg body weight intravenously as induction agent in patients undergoing off pump CABG Control Intervention2: Inj Etomidate Lippu

Eligibility

Inclusion criteria

Inclusion criteria: Patients undergoing Off pump CABG

Exclusion criteria

Exclusion criteria: Patients with pre-existing cardiac arrhythmias . Patients taken for emergency CABG or re-do surgery. Patients on steroid therapy or with known adrenal insufficiency.

Design outcomes

Primary

Measure	Time frame
To observe and compare the hemodynamic responses of etomidate and propofol in patients planned for CABG off pumpTimepoint: At Intubation,Every min for 10 min and then every 2 min for 30 min	—

Secondary

Measure	Time frame
Effect of etomidate on serum cortisolTimepoint: 24 hours after injection of Etomidate;To compare the requirement of ionotropic agents intra-operatively and post-operativelyTimepoint: Postoperatively till patient is discharged from Cardiac recovery	—

Countries

India

Contacts

Public ContactDr Shakuntala Basantwani

Lokmanya Tilak Municipal and General Hospital

dockanchan@gmail.com9850660650

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026